MICROVISION, INC.

Listed Company

MVISCIK 0000065770NasdaqNon-AcceleratedSmaller ReportingElectronic Components, NecDelawareFY ends Dec 31

Period

FY 2025

Revenue

$1.21M

Net Income

—

Total Assets

—

Equity

—

Shares Out

331.62M

Op. Cash Flow

$-58.72M

Business

MICROVISION, INC. develops integrated lidar hardware and perception software that combine deterministic AI at the edge with proprietary laser beam scanning and solid-state sensor technologies. It offers MEMS-based long-range MAVIN and flash-based MOVIA lidar sensors, a perception and application software stack, the MOSAIK validation suite, custom application software, and engineering services. The company sells solutions targeted to industrial mobility (robotics, AGVs/AMRs, warehouse automation, agriculture, mining), automotive OEMs and Tier 1 suppliers for ADAS/AD, and defense contractors. It markets B2B through account-based sales, OEM and Tier 1 partnerships, direct engagement, trade shows, and works with contract manufacturers and compute partners across North America and Europe.

Summary from filing dated 2025-03-26

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Revenue	1	5	7	—	—
Cost of revenue	19	8	3	100,000	2,000
Gross (loss) profit	−17	−3	4	564,000	2
Research and development expense	32	49	57	30	24
Sales, marketing, general and administrative expense	20	29	37	24	22
Impairment loss on intangible assets	10	4	—	—	—
Impairment loss on operating lease right-of-use assets	1	—	—	—	—
Impairment loss on property and equipment, net	2	—	—	—	—
Loss (gain) on disposal of fixed assets	—	143,000	−34,000	—	—
Total operating expenses	65	83	93	54	46
Loss from operations	−83	−86	−89	−54	−44
Bargain purchase gain, net of tax	—	—	2	—	—
Interest expense	−19	−4	−80,000	−62,000	—
Unrealized gain (loss) on derivative liability	6	−9	—	—	—
Unrealized gain on warrant liability	4	—	—	—	—
Realized loss on debt extinguishment	−5	—	—	—	692,000
Other income	817,000	2	6	861,000	—
Net loss before taxes	−95	−96	−82	−53	−43
Income tax benefit (expense)	84,000	−507,000	−1	—	—
Net loss	−95	−97	−83	−53	−43
Net loss per share, basic	−0.35	−0.46	−0.45	−0.32	−0.27
Net loss per share - diluted	−0.35	−0.46	−0.45	−0.32	−0.27
Weighted-average shares outstanding - basic	273	210	183	166	161
Weighted-average shares outstanding - diluted	273	210	183	166	161

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2023 2023-01-31	FY 2022 2022-12-31
Cash and cash equivalents	32	54	45	19	21
Investment securities, available-for-sale	42	20	—	—	—
Restricted cash, current	497,000	261,000	3	—	—
Accounts receivable, net of allowances	47,000	926,000	949,000	—	—
Inventory	745,000	2	4	—	2
Other current assets	5	4	5	—	2
Total current assets	81	82	87	—	91
Property and equipment, net	4	7	9	—	7
Operating lease right-of-use assets	14	17	14	—	15
Restricted cash, net of current portion	1	2	961,000	—	1
Intangible assets, net	32,000	11	17	—	75,000
Other assets	2	2	2	—	1
Total assets	103	121	130	—	115
Accounts payable	2	1	2	—	2
Accrued liabilities	5	3	9	—	2
Contract liabilities	—	308,000	—	—	—
Derivative liability	—	15	—	—	—
Notes payable, current	19	24	—	—	—
Operating lease liabilities, current	3	3	2	—	2
Finance lease liabilities, current	14,000	—	—	—	21,000
Other current liabilities	388,000	458,000	669,000	—	839,000
Total current liabilities	30	46	21	—	11
Notes payable, net of current portion	—	9	—	—	—
Warrant liability	2	—	—	—	—
Operating lease liabilities, net of current portion	14	16	13	—	14
Finance lease liabilities, net of current portion	27,000	—	—	—	0
Other long-term liabilities	1	2	614,000	—	—
Total liabilities	48	72	34	—	25
Commitments and contingencies (Note 12)	—	—	—	—	—
Preferred stock, par value $0.001; 25,000 shares authorized; zero and zero shares issued and outstanding as of December 31, 2025 and 2024	—	—	—	—	—
Common stock, par value $0.001; 510,000 shares authorized; 306,509 and 224,993 shares issued and outstanding as of December 31, 2025 and 2024, respectively	306,000	225,000	195,000	—	171,000
Additional paid-in capital	1,012	911	861	—	772
Accumulated other comprehensive income	669,000	—	210,000	—	−127,000
Accumulated deficit	−957	−862	−765	—	−683
Total shareholders equity	56	49	96	—	90
Total liabilities and shareholders equity	103	121	130	—	115

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Depreciation and amortization	6	7	8	2	1
Impairment of operating lease right-of-use assets	1	405,000	—	—	—
Impairment of property and equipment	2	—	12,000	—	—
Inventory write-downs	10	2	76,000	87,000	48,000
Non-cash interest expense	7	—	—	—	—
Amortization of debt discount and issuance costs on notes payable	11	4	—	—	—
Share-based compensation expense	701,000	12	16	15	15
Net accretion of premium on short-term investments	−532,000	−951,000	−1	21,000	86,000
Accounts receivable	879,000	23,000	−949,000	—	—
Inventory	−8	−495,000	−892,000	−168,000	−2
Other current and non-current assets	2	85,000	−2	—	—
Accounts payable	496,000	−1	942,000	−2	3
Accrued liabilities	3	−6	7	888,000	675,000
Contract liabilities and other current liabilities	−399,000	−188,000	−6	−293,000	−1
Operating lease liabilities	−3	−2	−3	−1	−762,000
Other long-term liabilities	−457,000	1	13,000	—	—
Net cash used in operating activities	−59	−69	−67	−38	−29
Sales of investment securities	30	35	77	61	—
Purchases of investment securities	−52	−26	−42	−90	−33
Advance to Scantinel	−2	—	—	—	—
Cash paid for Ibeo business combination	—	−6	−11	—	—
Purchases of property and equipment	−679,000	−374,000	−2	−4	−2
Net cash provided by (used in) investing activities	−25	3	22	−38	−35
Principal payments under finance leases	−13,000	—	−21,000	−26,000	−28,000
Principal payments under notes payable	−17	—	—	−392,000	—
Principal proceeds from notes payable, net of debt discount and issuance costs	—	38	—	—	—
Proceeds from stock option exercises	8,000	62,000	175,000	726,000	3
Net proceeds from issuance of common stock and warrants	77	35	72	14	123
Net cash provided by financing activities	61	73	72	14	131
Effect of exchange rate changes on cash and cash equivalents and restricted cash	316,000	−166,000	267,000	—	—
Change in cash, cash equivalents, and restricted cash	−22	7	27	−62	66
Common stock issued in conversion of note payable	22	4	—	—	—
Issuance of warrants	6	—	—	—	—
Amounts issued to escrow for acquisition consideration	—	—	6	—	—
Acquisition of right-of-use asset	137,000	5	1	—	—
Accrued financing fees	—	—	−32,000	—	—
Foreign currency translation adjustments	671,000	−210,000	184,000	—	—
Unrealized (loss) gain on investment securities, available-for-sale	−2,000	—	153,000	−108,000	−19,000

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro